| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Interest income, net | - | - | 68 | 442 |
| Pre-tax income(loss) | 44,717 | -9,774 | -9,266 | -12,702 |
| Income tax expense | 0 | 0 | - | - |
| Net income(loss) | 44,717 | -9,774 | -9,266 | -12,702 |
| Comprehensive loss | - | - | - | -12,702 |
| Earnings per share, basic | 1.07 | -0.23 | -0.22 | -0.31 |
| Earnings per share, diluted | 1.07 | -0.23 | -0.22 | -0.31 |
| Weighted average number of shares outstanding, basic | 41,788,096 | 41,788,096 | 41,771,213 | 41,588,035,000 |
| Weighted average number of shares outstanding, diluted | 41,940,292 | 41,788,096 | 41,771,213 | 41,588,035,000 |
Carisma Therapeutics Inc. (CARM)
Carisma Therapeutics Inc. (CARM)